middle.news
Cogstate’s Clinical Trial Sales More Than Double, Revenue Beats Forecasts
8:40am on Thursday 22nd of January, 2026 AEDT
•
Healthcare
Read Story
Cogstate’s Clinical Trial Sales More Than Double, Revenue Beats Forecasts
8:40am on Thursday 22nd of January, 2026 AEDT
Key Points
Clinical trial sales contracts jump 105% to $41.7 million
Total revenue rises 12% to $26.9 million, exceeding guidance
Earnings expected at top end of forecast margins
Diversification with 45% of sales from mood, sleep, and neurological conditions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cogstate (ASX:CGS)
OPEN ARTICLE